Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Brain Cancer Market Size Forecast: How Large Could The Market Become By 2030?
The market size for brain cancer has experienced robust growth in recent years. It is projected to expand from $3.35 billion in 2025 to $3.60 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.5%. This historical growth can be attributed to several factors, including an increase in brain cancer incidence, the growing adoption of neuroimaging techniques, a rising demand for chemotherapy and radiotherapy, expanding access to specialized cancer centers, and increasing healthcare expenditure.
The brain cancer market is projected for robust expansion over the coming years. This market is predicted to reach $4.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this growth during the forecast period include increasing demand for targeted treatments, greater uptake of immunotherapies, broader application of minimally invasive neurosurgical procedures, a heightened emphasis on early detection, and increased capital allocation in oncology infrastructure. Key trends anticipated during this period encompass advancements in AI-driven diagnostic instruments, the creation of customized medicine solutions, novel combinations in immunotherapy, strides in liquid biopsy technologies, and ongoing research and development efforts in high-precision imaging systems.
Download A Free Sample Report For Comprehensive Market Insights:
Brain Cancer Market Opportunity Drivers: What Is Creating New Revenue Potential?
The future expansion of the brain cancer market is anticipated to be fueled by the rising occurrence of neurological tumors. These tumors are defined as unusual, frequently malignant growths in the brain or central nervous system, which disrupt neurological functions and demand intricate medical care. The increasing incidence of neurological tumors stems from demographic changes like an aging and expanding population, given that advancing age elevates the likelihood of developing brain cancers. The brain cancer market addresses this heightened prevalence by enhancing diagnostic tools, treatment options, and care services to meet the evolving clinical requirements of the increasing patient base. For example, the American Cancer Society, a US-based non-profit, projected in January 2025 that for the year 2025, approximately 14,040 new cases of brain tumors and other nervous system cancers are anticipated in males and 10,780 in females, alongside an estimated 18,330 total deaths. Consequently, the expanding occurrence of neurological tumors is a primary factor stimulating the growth of the brain cancer market.
Brain Cancer Market Segments: Where Are The Largest Growth Opportunities?
The brain cancer market covered in this report is segmented –
1) By Product Type: Therapeutic Treatments, Diagnostic Imaging, Surgical Devices, Supportive Care Products
2) By Surgical Treatment: Tumor Resection, Minimally Invasive Surgery, Stereotactic Surgery
3) By Diagnosis: Imaging Techniques, Biopsy, Molecular Testing, Genetic Testing
4) By Supportive Care: Rehabilitation, Palliative Care, Counseling, Follow-Up Care
5) By End User: Hospitals, Specialty Clinics, Research Institutes
Subsegments:
1) By Therapeutic Treatments: Chemotherapy Drugs, Targeted Therapy Drugs, Immunotherapy Agents, Radiation Therapy Products, Hormone Therapy Products, Tumor Treating Fields Devices
2) By Diagnostic Imaging: Magnetic Resonance Imaging Systems, Computed Tomography Scanners, Positron Emission Tomography Systems, Ultrasound Imaging Systems, Nuclear Imaging Systems
3) By Surgical Devices: Neurosurgical Navigation Systems, Craniotomy Instruments, Neuroendoscopy Devices, Surgical Microscopes, Stereotactic Surgical Equipment
4) By Supportive Care Products: Pain Management Medications, Anti Nausea Medications, Nutritional Support Products, Rehabilitation Equipment, Symptom Management Products
Brain Cancer Market Innovation Trends Driving Future Development
Leading firms within the brain cancer market are prioritizing the creation of sophisticated diagnostic and imaging instruments, including AI-powered MRI segmentation platforms, aiming to enhance clinical judgment and optimize treatment strategies. These AI-driven MRI segmentation platforms are defined as software applications that employ artificial intelligence to automatically pinpoint and outline anatomical features or abnormalities on MRI images, thereby facilitating quicker and more uniform diagnosis and treatment formulation. An example of this is seen in July 2025, when Cortechs.ai, a US-based medical imaging software company, introduced NeuroQuant Brain Tumor. This product features improved AI-driven MRI segmentation models, providing automated volumetric quantification and segmentation for metastasis/meningioma, which boosts radiologist efficiency and diagnostic consistency over manual methods, along with cloud deployment and PACS integration for quick scalability. Through its delivery of objective segmentations and volumetric reports, this advanced technology enhances the effectiveness and standardization for radiologists, neurosurgeons, and neuro-oncologists, concurrently saving time and increasing clinical consistency and diagnostic certainty. This allows clinicians to directly contribute to better patient outcomes by observing tumor alterations over time and acquiring critical insights into treatment effectiveness and the progression of the disease.
Brain Cancer Market Major Participants And Competitive Dynamics
Major companies operating in the brain cancer market are Providence Health & Services, Ascension Health, Trinity Health, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Cleveland Clinic, The Mount Sinai Hospital, The University of Texas MD Anderson Cancer Center, CommonSpirit Health, City of Hope National Medical Center, Stanford Health Care, Apollo Hospitals Enterprise Limited, Elekta AB, H. Lee Moffitt Cancer Center & Research Institute Inc., Roswell Park Comprehensive Cancer Center, Fred Hutchinson Cancer Center, Fortis Healthcare Limited, Dana-Farber Cancer Institute Inc., The Johns Hopkins Hospital, The Regents of the University of California
Access The Complete Brain Cancer Market Report:
Brain Cancer Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the brain cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model